Consistently, the protein and mRNA detection showed that the RanBP3 levels in CML cells (BCR-ABL+) were much higher than that of other leukemia cells (BCR-ABL-) (Figures 1C, D). Here, RANBP3 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.